EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals

Manuel V Borca, Elizabeth Ramirez-Medina, Nallely Espinoza, Ayushi Rai, Edward Spinard iD, Lauro Velazquez-Salinas, Alyssa Valladares, Ediane Silva iD, Leeanna Burton iD, Amanda Meyers, Jason Clark, Ping Wu iD und 2 weitere

Viruses · 2024

DOI: 10.3390/v16030376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Manuel V Borca und 13 weiteren Autor:innen. Beteiligte Einrichtung: Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11…. Hauptthemen laut MEDLINE: African Swine Fever Virus, African Swine Fever, Viral Vaccines. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Pork Board, Foundation for Food and Agriculture, National Pork Board Project #21-137.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The African swine fever virus (ASFV) mutant ASFV-G-∆I177L is a safe and efficacious vaccine which induces protection against the challenge of its parental virus, the Georgia 2010 isolate. Although a genetic DIVA (differentiation between infected and vaccinated animals) assay has been developed for this vaccine, still there is not a serological DIVA test for differentiating between animals vaccinated with ASFV-G-∆I177L and those infected with wild-type viruses. In this report, we describe the development of the ASFV-G-∆I177L mutant having deleted the EP402R gene, which encodes for the viral protein responsible for mediating the hemadsorption of swine erythrocytes. The resulting virus, ASFV-G-∆I177L/∆EP402R, does not have a decreased ability to replicates in swine macrophages when compared with the parental ASFV-G-∆I177L. Domestic pigs intramuscularly (IM) inoculated with either 102 or 106 HAD50 of ASFV-G-∆I177L/∆EP402R remained clinically normal, when compared with a group of mock-vaccinated animals, indicating the absence of residual virulence. Interestingly, an infectious virus could not be detected in the blood samples of the ASFV-G-∆I177L/∆EP402R-inoculated animals in either group at any of the time points tested. Furthermore, while all of the mock-inoculated animals presented a quick and lethal clinical form of ASF after the intramuscular inoculation challenge with 102 HAD50 of highly virulent parental field isolate Georgia 2010 (ASFV-G), all of the ASFV-G-∆I177L/∆EP402R-inoculated animals were protected, remaining clinically normal until the end of the observational period. Most of the ASFV-G-∆I177L/∆EP402R-inoculated pigs developed strong virus-specific antibody responses against viral antigens, reaching maximum levels at 28 days post inoculation. Importantly, all of the sera collected at that time point in the ASFV-G-∆I177L/∆EP402R-inoculated pigs did not react in a direct ELISA coated with the recombinant EP402R protein. Conversely, the EP402R protein was readily recognized by the pool of sera from the animals immunized with recombinant live attenuated vaccine candidates ASFV-G-∆I177L, ASFV-G-∆MGF, or ASFV-G-∆9GL/∆UK. Therefore, ASFV-G-∆I177L/∆EP402R is a novel, safe and efficacious candidate with potential to be used as an antigenically DIVA vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

African Swine Fever VirusAfrican Swine FeverViral VaccinesSwineAnimalsSus scrofaVirulenceVaccines, SyntheticVaccines, AttenuatedRecombinant ProteinsGene Deletion

Stichwörter der Autor:innen

ASF vaccineAfrican swine feverAfrican swine fever virusEP402R marker vaccineEp402RI177L

Substanzen

Viral VaccinesVaccines, SyntheticVaccines, AttenuatedRecombinant Proteins

Autor:innen und Institutionen

  • Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.
  • Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
  • Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
  • Plum Island Animal Disease Center, U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Orient, NY 11957, USA.
  • Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA.

ORCID-Profile: Edward Spinard, Ediane Silva, Leeanna Burton, Ping Wu, Douglas P Gladue

Förderung

  • National Pork Board
  • Foundation for Food and Agriculture
  • National Pork Board Project #21-137
  • Foundation for Food and Agriculture Rapid Outcomes from Agriculture Research (ROAR)

Zitieren

APA

Borca, M. V., Ramirez-Medina, E., Espinoza, N., Rai, A., Spinard, E., Velazquez-Salinas, L., Valladares, A., Silva, E., Burton, L., Meyers, A., Clark, J., Wu, P., Gay, C. G., & Gladue, D. P. (2024). Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals. Viruses. https://doi.org/10.3390/v16030376

Vancouver

Borca MV, Ramirez-Medina E, Espinoza N, Rai A, Spinard E, Velazquez-Salinas L, et al. Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals. Viruses. 2024. doi:10.3390/v16030376

BibTeX
@article{Borca2024,
  author = {Borca, Manuel V and Ramirez-Medina, Elizabeth and Espinoza, Nallely and Rai, Ayushi and Spinard, Edward and Velazquez-Salinas, Lauro and Valladares, Alyssa and Silva, Ediane and Burton, Leeanna and Meyers, Amanda and Clark, Jason and Wu, Ping and Gay, Cyril G and Gladue, Douglas P},
  title = {Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16030376}
}
Kostenlos starten →